Literature DB >> 21978387

Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with Type 2 diabetes and early nephropathy.

Y Wada1, Y Hamamoto, H Ikeda, S Honjo, Y Kawasaki, K Mori, H Koshiyama.   

Abstract

AIMS: It has been recognized that blood pressure shows a seasonal variation, but it remains unknown whether diabetic nephropathy shows a seasonal variation. In the present study, we investigated the change in urinary albumin/creatinine ratio in relation to the season in Japanese patients with Type 2 diabetes.
METHODS: A total of 430 subjects (275 male, 155 female) with Type 2 diabetes and early nephropathy (defined by UACR 30-300 mg/g creatinine) were included. One year was divided into four seasons and each season was defined as winter (December-February), spring (March-May), summer (June-August), and fall (September-November), and systolic and diastolic blood pressure, serum creatinine levels, and the urinary albumin/creatinine ratio were examined. The estimated glomerular filtration rate was also calculated and evaluated.
RESULTS: The mean age (± SE) was 64.8 ± 0.8 years. The mean systolic blood pressure was significantly higher in winter than in summer (136 ± 0.68 vs. 133 ± 0.68 mmHg, P < 0.001). The urinary albumin/creatinine ratio showed a significantly higher value in winter than in summer (72.8 ± 4.4 vs. 54.6 ± 3.4 mg/g creatinine, P < 0.001). The curve of seasonal variation of this ratio showed a similar change to that of systolic blood pressure. No significant seasonal variation was observed in estimated glomerular filtration rate and diastolic blood pressure.
CONCLUSIONS: Our results suggest that there is a hitherto unknown seasonal variation in the urinary albumin/creatinine ratio, and that it may be necessary to consider this seasonal change, especially when performing an intervention study of nephropathy.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21978387     DOI: 10.1111/j.1464-5491.2011.03472.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia.

Authors:  Hiroshi Matsuo; Eiji Ishikawa; Hirofumi Machida; Yasuhide Mizutani; Akiko Tanoue; Takahiro Ohnishi; Tomohiro Murata; Shinya Okamoto; Toru Ogura; Yuki Nishimura; Hiroo Ito; Masashi Yasutomi; Kan Katayama; Shinsuke Nomura; Masaaki Ito
Journal:  Clin Exp Nephrol       Date:  2019-12-16       Impact factor: 2.801

2.  Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study.

Authors:  Masahiro Naruse; Masashi Mukoyama; Jun Morinaga; Masanobu Miyazaki; Kunitoshi Iseki; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2019-09-20       Impact factor: 2.801

3.  Blood Pressure Seasonality in Diabetic Patients: A Call for Attention.

Authors:  Yonit Marcus; Naftali Stern
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-31       Impact factor: 3.738

4.  Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.

Authors:  Koji Inagaki; Yoshinari Yasuda; Masahiko Ando; Ahmad Baseer Kaihan; Asaka Hachiya; Takaya Ozeki; Manabu Hishida; Takahiro Imaizumi; Takayuki Katsuno; Sawako Kato; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

5.  Seasonal Variation in Blood Pressure in 162,135 Patients With Type 1 or Type 2 Diabetes Mellitus.

Authors:  Julia M Hermann; Joachim Rosenbauer; Axel Dost; Claudia Steigleder-Schweiger; Wieland Kiess; Christof Schöfl; Reinhard W Holl
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-10       Impact factor: 3.738

6.  Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: The J-HOP Study (Japan Morning Surge-Home Blood Pressure).

Authors:  Keisuke Narita; Satoshi Hoshide; Takeshi Fujiwara; Hiroshi Kanegae; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2020-07-18       Impact factor: 2.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.